PEGBIO CO-B 02565Hong Kong Stock Exchange

4.6903.50%( -0.170 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
PEGBIO CO-B (02565) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
PegBio Co., Ltd.
Market
HKEX Main Board
Listing Date
2025-05-27
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100006T44
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Net Profit (Last FY)-244.34M83/125
ROE (Last FY)-46.46%97/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Michael Min XU Executive Director
王小军 Executive Director
Xiangjun ZHOU Executive Director
徐宇虹 Executive Director
翟婷 Executive Director
李宏凯 Executive Director
Jiancun ZHANG Executive Director
陈秧秧 Executive Director
廖亦琳 Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-24.

About this page

This page shows PEGBIO CO-B (02565) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.